Consolidative Local Therapy in Oligometastatic Patients

The Lancet Oncology- United Kingdom

doi 10.1016/s1470-2045(17)30013-x

Full Text

Abstract

Available in

Date

February 1, 2017

Authors

Publisher

Elsevier BV

Related search

OA07.06 Efficacy of Local Consolidative Therapy for Oligometastatic Lung Adenocarcinoma Patients Harboring EGFR Mutations.

Journal of Thoracic Oncology

English

MA25.06 RPA Analysis for Oligometastatic Non-Small Cell Lung Cancer: Smoking Combine T3/4 Patients May Not Be Benefit From Local Consolidative Treatment

Journal of Thoracic Oncology

English

OA07.05 Local Ablative Therapy Improves Survival in Patients With Synchronous Oligometastatic NSCLC Harboring EGFR Mutation Treated With EGFR-TKIs

Journal of Thoracic Oncology

English

Imaging Oligometastatic Cancer Before Local Treatment

The Lancet Oncology

Oncology

2016

English

Stereotactic Body Radiation Therapy (SBRT) in Patients With Hepatocellular Carcinoma and Oligometastatic Liver Disease

English

P3.08-04 OMEGA, a Randomized Trial of Local Ablative Therapy vs. Conventional Treatment in Oligometastatic NSCLC – Trial in Progress

Journal of Thoracic Oncology

English

P3.01-69 Stereotactic Ablative Radiotherapy Improves Progression-Free Survival and Local Control in Oligometastatic Lung Cancer Patients

Journal of Thoracic Oncology

English

Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer

International Journal of Radiation Oncology Biology Physics

English

Autologous T-Cell Therapy for Cytomegalovirus as a Consolidative Treatment for Recurrent Glioblastoma

Cancer Research

Oncology

2014

English

Amanote Research

Consolidative Local Therapy in Oligometastatic Patients

The Lancet Oncology- United Kingdom

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

OA07.06 Efficacy of Local Consolidative Therapy for Oligometastatic Lung Adenocarcinoma Patients Harboring EGFR Mutations.

MA25.06 RPA Analysis for Oligometastatic Non-Small Cell Lung Cancer: Smoking Combine T3/4 Patients May Not Be Benefit From Local Consolidative Treatment

OA07.05 Local Ablative Therapy Improves Survival in Patients With Synchronous Oligometastatic NSCLC Harboring EGFR Mutation Treated With EGFR-TKIs

Imaging Oligometastatic Cancer Before Local Treatment

Stereotactic Body Radiation Therapy (SBRT) in Patients With Hepatocellular Carcinoma and Oligometastatic Liver Disease

P3.08-04 OMEGA, a Randomized Trial of Local Ablative Therapy vs. Conventional Treatment in Oligometastatic NSCLC – Trial in Progress

P3.01-69 Stereotactic Ablative Radiotherapy Improves Progression-Free Survival and Local Control in Oligometastatic Lung Cancer Patients

Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer

Autologous T-Cell Therapy for Cytomegalovirus as a Consolidative Treatment for Recurrent Glioblastoma